Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AgeWa: an integrated approach for antisense experiment design.

Patrizio Arrigo1, Paolo Scartezzini, Paolo Romano

  • 1CNR Institute of Macromolecular Studies (ISMAC), via de Marini 6, 16149 Genova, Italy. arrigo@ge.ismac.cnr.it

IEEE Transactions on Nanobioscience
|May 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive European Colorectal Cancer Cohort dataset.

Scientific data·2026
Same author

Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience.

The new microbiologica·2024
Same author

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor <i>in vivo</i> acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.

Frontiers in pharmacology·2024
Same author

"Be sustainable": EOSC-Life recommendations for implementation of FAIR principles in life science data handling.

The EMBO journal·2023
Same author

Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs.

Open research Europe·2023
Same author

BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.

Viruses·2023

Developing new drugs requires understanding disease mechanisms and identifying gene targets. This study introduces Automatic Gene Walk (AgeWa), a tool that combines neural networks and database mining to predict optimal targets for antisense oligonucleotides (ASO) therapy.

Area of Science:

  • Genomics
  • Molecular Biology
  • Drug Discovery

Background:

  • The Human Genome Project highlights the need to understand molecular disease mechanisms.
  • Identifying disease-associated genes and their interactions is crucial for drug design.
  • Gene expression analysis technologies like microarrays enable large-scale gene evaluation.

Purpose of the Study:

  • To address the lack of standardized procedures for selecting effective antisense oligonucleotide (ASO) targets.
  • To introduce a novel computational tool for optimizing ASO target selection.
  • To facilitate the development of new therapeutic strategies based on ASO technology.

Main Methods:

  • Development of the Automatic Gene Walk (AgeWa) tool.
  • Integration of a neural filter with database mining techniques.

Related Experiment Videos

  • Application of the tool for predicting optimal nucleotide domains for antisense action.

    • Main Results:

    • AgeWa provides an integrative approach for ASO target selection.
    • The tool combines computational methods for enhanced prediction accuracy.
    • Demonstrates a standardized procedure for identifying effective ASO targets.

    Conclusions:

    • AgeWa offers a promising solution for ASO target identification.
    • This approach can accelerate the drug discovery and development pipeline.
    • Standardized target selection is essential for the successful application of antisense technology.